Arvoni Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-07-2024
- Paid Up Capital ₹ 0.50 M
as on 06-07-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 3.27%
(FY 2022)
- Profit -47.64%
(FY 2022)
- Ebitda -159.37%
(FY 2022)
- Net Worth 47.16%
(FY 2022)
- Total Assets 63.69%
(FY 2022)
About Arvoni Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Harpreet Kaur, Rupinder Singh, Vineet Arora, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999PB2019PTC048852
- Company No.
048852
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Mohali, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Arvoni Lifesciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raman Lamba  | Director | 02-Jan-2019 | Current |
| Harpreet Kaur | Director | 02-Jan-2019 | Current |
| Rupinder Singh | Director | 02-Jan-2019 | Current |
| Vineet Arora | Director | 02-Jan-2019 | Current |
Financial Performance of Arvoni Lifesciences.
Arvoni Lifesciences Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.27% increase. The company also saw a substantial fall in profitability, with a 47.64% decrease in profit. The company's net worth Soared by an impressive increase of 47.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arvoni Lifesciences?
Unlock access to Arvoni Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Novique Lifesciences Private LimitedActive 6 years 12 daysVineet Arora and Raman Lamba are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Arvoni Lifesciences?
Unlock and access historical data on people associated with Arvoni Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arvoni Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arvoni Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
